✦ LIBER ✦

Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b

✍ Scribed by C. Polman; L. Kappos; M. S. Freedman; G. Edan; H.-P. Hartung; D. H. Miller; X. Montalbán; F. Barkhof; K. Selmaj; B. M. J. Uitdehaag; S. Dahms; L. Bauer; C. Pohl*; R. Sandbrink*; for the BENEFIT investigators**

Book ID: 106093682
Publisher: Springer
Year: 2007
Tongue: English
Weight: 321 KB
Volume: 255
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-007-0733-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The OPTimization of Interferon for MS St

The OPTimization of Interferon for MS Study: 375 μg interferon beta-1b in suboptimal responders

✍ L. Durelli; P. Barbero; M. Bergui; E. Versino; M. A. Bassano; E. Verdun; B. Ferr 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 283 KB

The effect of IFN-beta 1b in viral load

The effect of IFN-beta 1b in viral load in serum samples of MS patients

✍ H. Zahednasab; H. Khodabandehloo; S. A. Bahreini 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

Interferon beta treatment of MS in the d

Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study

✍ E. Onesti; F. Bagnato; V. Tomassini; G. Volante; F. Denaro; M. Frontoni; E. Mill 📂 Article 📅 2003 🏛 Springer Milan 🌐 English ⚖ 93 KB

Human herpesvirus 6 and effectiveness of

Human herpesvirus 6 and effectiveness of interferon beta 1b in multiple sclerosis patients

✍ M. Garcia-Montojo; V. De Las Heras; M. Dominguez-Mozo; M. Bartolome; M. A. Garci 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

Effects of interferon beta-1a and -1b ov

Effects of interferon beta-1a and -1b over time: 6-year results of an observational head-to-head study

✍ F. Patti; A. Pappalardo; C. Florio; G. Politi; T. Fiorilla; E. Reggio; A. Reggio 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Effect of denosumab treatment on the ris

Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis

✍ Michael R McClung; Steven Boonen; Ove Törring; Christian Roux; René Rizzoli; Hen 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 103 KB 👁 1 views

## Abstract Denosumab reduces the risk of new vertebral and nonvertebral fractures. Previous trials suggest that the efficacy of antiresorptives on fractures might differ by patients' characteristics, such as age, bone mineral density (BMD), and fracture history. In the FREEDOM study, 7808 women ag